Health Insurance (Pathology Services Table) Amendment Regulation 2012 (No. 1)1
Select Legislative Instrument 2012 No. 58
I, QUENTIN BRYCE, Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulation under the Health Insurance Act 1973.
Dated 19 April 2012
QUENTIN BRYCE
Governor-General
By Her Excellency’s Command
TANYA PLIBERSEK
Minister for Health
1              Name of regulation
                This regulation is the Health Insurance (Pathology Services Table) Amendment Regulation 2012 (No. 1).
2              Commencement
                This regulation commences on 1 May 2012.
3              Amendment of Health Insurance (Pathology Services Table) Regulations 2011
                Schedule 1 amends the Health Insurance (Pathology Services Table) Regulations 2011.
Schedule 1        Amendments of Schedule 1 to the Health Insurance (Pathology Services Table) Regulations 2011
(section 3)
 
[1]           After item 73327
insert
73328
A test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to gefitinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled
400.00

73330
A test of tumour tissue from a patient with metastatic colorectal cancer requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to Kirsten ras (KRAS) gene mutation status for access to cetuximab under the Pharmaceutical Benefits Scheme (PBS) are fulfilled
232.50

73332
An in situ hybridization (ISH) test of tumour tissue from a patient with breast cancer (other than in the neoadjuvant setting) requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to human epidermal growth factor receptor 2 (HER2) gene mutation status for access to trastuzumab under the Pharmaceutical Benefits Scheme (PBS) or the Herceptin Program are fulfilled
317.50

[2]           Subclause 2.10.1 (7), note
omit
[3]           Group P10
omit
Subgroup 1 — Initiation of a patient episode involving particular services
[4]           Items 73924 to 73927
substitute
73924
Initiation of a patient episode that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 (in circumstances other than those described in item 73925) from a person who is an in‑patient of a hospital
14.75

73925
Initiation of a patient episode that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 if the person is:
   (a)  a private patient of a recognised hospital; or
2.40

 
  (b)  a private patient of a hospital who receives the service or services from a prescribed laboratory
 

73926
Initiation of a patient episode that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 (in circumstances other than those described in item 73927) from a person who is not a patient of a hospital
8.25

73927
Initiation of a patient episode by a prescribed laboratory that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 from a person who is not a patient of a hospital
2.40

[5]           Group P10
omit
Subgroup 2 — Initiation of a patient episode involving other services
Note
1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See www.comlaw.gov.au.